C39H67N5O7
718 g/mol
Pharmaceutical IntermediateDanger
Monomethyl auristatin E
CAS474645-27-7
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate
Monomethyl auristatin E is a complex peptide-based compound used as a pharmaceutical intermediate in the manufacturing of antibody-drug conjugates. Its structure features multiple amide groups, an aromatic ring, and several chiral centers, contributing to its role as a key building block in targeted therapeutic development.
pharmaceutical intermediate for antibody-drug conjugate manufacturing
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 474645-27-7
Related Compounds
StrongStructure SimilarSimilarity 0.87
(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide
CAS160800-57-7
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.78
Monomethyl auristatin F
CAS745017-94-1
pharmaceutical intermediate
SimilarStructure SimilarSimilarity 0.73
Mc-MMAE
CAS863971-24-8
pharmaceutical raw material
ApplicationSame Use
MC-Gly-Gly-Phe-Gly
CAS2413428-36-9
pharmaceutical intermediate
ApplicationSame Use
N-Acetyl calicheamicin
CAS108212-76-6
pharmaceutical intermediate
ReferenceSame Category
Bicyclo[3.1.1]heptane-2-ethanol, 6,6-dimethyl-
CAS4747-61-9
pharmaceutical intermediate
ReferenceSame Category
Tert-Butyl 3,4-dihydroxypiperidine-1-carboxylate
CAS475062-48-7
pharmaceutical intermediate
ReferenceSame Category
5-Bromo-N-(butoxycarbonyl)indole-2-boronic acid
CAS475102-13-7
pharmaceutical intermediate
Safety Reference
Danger
H300Fatal if swallowed
H330Fatal if inhaled
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H340May cause genetic defects
H341Suspected of causing genetic defects
H360May damage fertility or the unborn child
H370Causes damage to organs
H372Causes damage to organs through prolonged or repeated exposure
H412Harmful to aquatic life with long lasting effects
Identifiers
IUPAC Name
(2S)-N-[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamide
InChIKey
DASWEROEPLKSEI-UIJRFTGLSA-N
SMILES
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC
Synonyms (22)
- 4Q5
- MMAE
- MMAE peptide
- Monomethyl auristatin E
- Monomethyl auristatin E (GMP)
- [3H]-Vedotin